Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01700257 · ClinicalTrials.gov registry record · NA
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
A NA study, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 1,361
- Enrollment target
NCT01700257: Completed NA study, sponsored by National Jewish Health.
NCT01700257 is a NA study that has completed, run by National Jewish Health. The registered enrollment target is 1,361 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01700257, a NA study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,361 participants
- Enrollment target
Study Summary
Lung cancer is the number one cancer killer in the USA. Early stage lung cancer is asymptomatic. Most patients with lung cancer are usually symptomatic at diagnosis and already have advanced stage disease. Low dose CT screening (LDCT) for high risk individuals has recently been shown to decrease lung cancer mortality by 20%. However, 4 out of 5 lung cancer deaths are not prevented with LDCT screening alone.
Primary Outcome
Assess the number of lung cancers detected with CT alone vs. with both Early CDT-Lung test and CT scan. Compare positive CT results with positive/negative Early CDT Lung test results and assess ability of the combination to detect earlier stage lung cancer.
Interventions
- RADIATION CT scan & Early CDT Lung test
- OTHER CT scan & Early CDT Lung test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,361 participants |
| Start Date | 2012-05 |
| Est. Completion | 2020-12-07 |
| Phase | NA |
What the finished NCT01700257 record still lists
NCT01700257 is an interventional study that assigns participants to a tested intervention. Its 1,361 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which CT scan & Early CDT Lung test is the first listed.
NCT01700257 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01700257 about?
NCT01700257 is a clinical study titled "Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker". Lung cancer is the number one cancer killer in the USA. Early stage lung cancer is asymptomatic. Most patients with lung cancer are usually symptomatic at diagnosis and already have advanced stage disease. Low dose CT screening (LDCT) for high risk individuals has recently been shown to decrease lun...
What is the current status of trial NCT01700257?
This trial is currently completed. It is a NA study. The enrollment target is 1,361 participants. The study started on 2012-05. Estimated completion is 2020-12-07.
What interventions are being tested in trial NCT01700257?
The interventions under investigation include: CT scan & Early CDT Lung test (RADIATION), CT scan & Early CDT Lung test (OTHER).
Who is sponsoring clinical trial NCT01700257?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01700257's enrollment target sits among peer trials
1,361 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia